TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29771567

Group type: EXPERIMENTAL
Intervention: Pre-eating ritual over a 5-day period
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pairing a ritual with healthy eating behavior
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enacting a ritual before a food choice
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ritualized gestures not explicitly labeled as a ritual
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rituals in prosocial decision-making
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rituals affecting responses to self-control conflicts
Number of subjects: 6
Study: 27258430

Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HBHCT) with immediate referral to TasP clinics for ART
Number of subjects: 1323

Group type: COMPARATOR
Intervention: Home-based HIV counselling and testing (HBHCT) with referral according to national guidelines
Number of subjects: 1323

Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HBHCT)
Number of subjects: 1323
Study: 24430001

Group type: EXPERIMENTAL
Intervention: Low-dose, transdermal 17β-estradiol
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen
Number of subjects: 571

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 571
Study: 22541797

Group type: EXPERIMENTAL
Intervention: Vaccination with TSOL16 and TSOL18 (200 μg each, plus 5mg Quil‐A)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (unvaccinated pigs)
Number of subjects: 137
Study: 20167888

Group type: EXPERIMENTAL
Intervention: Experience Corps participation in volunteer roles in public schools designed to increase healthy behaviors.
Number of subjects: 155
Study: 18605851

Group type: EXPERIMENTAL
Intervention: Availability of an attractive alternative (AA) relationship partner
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Implementation intention induction
Number of subjects: 7
Study: 16079444

Group type: EXPERIMENTAL
Intervention: Levobupivacaine (0.5%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (lidocaine)
Number of subjects: 60
Study: 12429158

Group type: EXPERIMENTAL
Intervention: Bicalutamide (B)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Goserelin plus flutamide (G+F)
Number of subjects: 220
Study: 10720834

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate
Number of subjects: 256

Group type: COMPARATOR
Intervention: Picolax
Number of subjects: 256
Study: 8795875

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1594212

Group type: EXPERIMENTAL
Intervention: Disposable latex cover over the pneumotonometer tip
Number of subjects: 187

Group type: COMPARATOR
Intervention: Uncovered pneumotonometer tip
Number of subjects: 187
Study: 6732270

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salicylates
Number of subjects: 0
Study: 31343124

Group type: EXPERIMENTAL
Intervention: CXA-10 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CXA-10 coadministration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CXA-10 (all doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CXA-10
Number of subjects: 0
Study: 30123047

Group type: EXPERIMENTAL
Intervention: Laser therapy at 658 nm
Number of subjects: 67

Group type: COMPARATOR
Intervention: Laser therapy at 940 nm
Number of subjects: 67

Group type: COMPARATOR
Intervention: Laser therapy at 808 nm
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sham therapy (control group)
Number of subjects: 67
Study: 26801148

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (Group 1)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (Group 2)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cycle ergometer and inspiratory muscle training (Group 3)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (Group 4)
Number of subjects: 43
Study: 25230735

Group type: EXPERIMENTAL
Intervention: 10-week inter-donation interval
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: 8-week inter-donation interval
Number of subjects: 50000

Group type: COMPARATOR
Intervention: 12-week inter-donation interval
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: 14-week inter-donation interval
Number of subjects: 50000

Group type: COMPARATOR
Intervention: Standard 16-week inter-donation interval
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Donor quality of life assessed using the Short Form Health Survey
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Deferrals due to low haemoglobin and other factors
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Iron status
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Cognitive function
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 50000

Group type: EXPERIMENTAL
Intervention: Donor attitudes
Number of subjects: 50000
Study: 23157894

Group type: EXPERIMENTAL
Intervention: Healthy Start to Pregnancy workshop
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual care (nutrition resource)
Number of subjects: 360
Study: 21044293

Group type: EXPERIMENTAL
Intervention: CT examinations of the chest and upper abdomen
Number of subjects: 29900000

Group type: EXPERIMENTAL
Intervention: Lower abdominal CT
Number of subjects: 29900000

Group type: EXPERIMENTAL
Intervention: Annual effective dose per capita for Japan
Number of subjects: 29900000

Group type: EXPERIMENTAL
Intervention: Annual collective effective dose in Japan
Number of subjects: 29900000

Group type: EXPERIMENTAL
Intervention: CT examinations
Number of subjects: 29900000
Study: 17356942

Group type: EXPERIMENTAL
Intervention: Diet enriched with arginine, omega-3 fatty acids, and ribonucleic acid (RNA) for 6 days preoperatively, followed by the same diet postoperatively.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-fiber diet for 6 days preoperatively, followed by restoration of oral nutrition on postoperative day 3.
Number of subjects: 28
Study: 15863547

Group type: EXPERIMENTAL
Intervention: Isopropanolic black cohosh extract (40 mg daily for 12 weeks)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo (matching tablets)
Number of subjects: 304
Study: 11717642

Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage with bed rest
Number of subjects: 35

Group type: COMPARATOR
Intervention: Bed rest alone
Number of subjects: 35
Study: 9228509

Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.2 U/kg body weight)
Number of subjects: 17

Group type: COMPARATOR
Intervention: U40 insulin (0.2 U/kg body weight)
Number of subjects: 17

Group type: COMPARATOR
Intervention: U100 soluble insulin
Number of subjects: 17
Study: 8127293

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study: 3476002

Group type: EXPERIMENTAL
Intervention: Supplemental ascorbic acid 500 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Supplemental ascorbic acid 1000 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2198977

Group type: EXPERIMENTAL
Intervention: Intramuscular depot methylprednisolone acetate (120 mg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 31887168

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 225
Study: 27363929

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 12 weeks)
Number of subjects: 60
Study: 26003873

Group type: EXPERIMENTAL
Intervention: ABM
Number of subjects: 65
Study: 23053132

Group type: EXPERIMENTAL
Intervention: Intensive unilateral neuromuscular training (IUNT) focusing on the non-dominant side of the low back for 8 weeks.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regular training (control group) for 8 weeks.
Number of subjects: 16
Study: 21586444

Group type: EXPERIMENTAL
Intervention: Airtraq® laryngoscope
Number of subjects: 90

Group type: COMPARATOR
Intervention: C‐MAC® laryngoscope
Number of subjects: 90

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 90
Study: 19393784

Group type: EXPERIMENTAL
Intervention: Speed Enforcement Program (SEP) implemented on the freeway
Number of subjects: 0
Study: 16481946

Group type: EXPERIMENTAL
Intervention: Single IV bolus of 500 mg of methylprednisolone
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 14966714

Group type: EXPERIMENTAL
Intervention: Unstable support surface with trunk stability task
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unstable support surface with head tracking task
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unstable support surface with object grasping task
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patients with multiple sclerosis
Number of subjects: 20
Study: 11393591

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study: 9232707

Group type: EXPERIMENTAL
Intervention: Treatment for functional gastrointestinal disorders over a four-week period
Number of subjects: 615
Study: 8127946

Group type: EXPERIMENTAL
Intervention: d,l‐fenfluramine (60 mg PO)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3609114

Group type: EXPERIMENTAL
Intervention: Endralazine 5 mg administered before breakfast
Number of subjects: 8

Group type: COMPARATOR
Intervention: Endralazine 5 mg administered after breakfast
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Endralazine 10 mg administered before breakfast
Number of subjects: 8

Group type: COMPARATOR
Intervention: Endralazine 10 mg administered after breakfast
Number of subjects: 8
Study: 29181658

Group type: EXPERIMENTAL
Intervention: Ferric citrate hydrate (FCH)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium ferrous citrate (SFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 28497058

Group type: EXPERIMENTAL
Intervention: Intensive handwashing promotion
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control
Number of subjects: 253
Study: 25638248

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 861

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 861
Study: 23190184

Group type: EXPERIMENTAL
Intervention: Oral Methotrexate (PO MTX) 25 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Subcutaneous Methotrexate (SC MTX) 25 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Comparison of PO and SC MTX
Number of subjects: 11
Study: 21261406

Group type: EXPERIMENTAL
Intervention: CRA plus vouchers
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study: 19922572

Group type: EXPERIMENTAL
Intervention: Intranasal naloxone (2 mg)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Intramuscular naloxone (2 mg)
Number of subjects: 172
Study: 16500494

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Doppler-derived LV filling indices
Number of subjects: 57
Study: 15154115

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of rh-alpha GalA (agalsidase beta, Fabrazyme, Genzyme Corporation) biweekly for 30-36 months
Number of subjects: 58
Study: 11318051

Group type: EXPERIMENTAL
Intervention: Priming with malleable rotating objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Priming with rigid rotating objects
Number of subjects: 0
Study: 9222729

Group type: EXPERIMENTAL
Intervention: Immunoalkaline phosphatase (IALP) technique
Number of subjects: 122

Group type: COMPARATOR
Intervention: Immunofluorescence (IF) technique
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: IALP technique (USA)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: IALP technique (Sweden)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: IALP technique (Norway)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: IALP technique (Italy)
Number of subjects: 122

Group type: COMPARATOR
Intervention: IF technique (USA)
Number of subjects: 122

Group type: COMPARATOR
Intervention: IF technique (Sweden)
Number of subjects: 122

Group type: COMPARATOR
Intervention: IF technique (Norway)
Number of subjects: 122

Group type: COMPARATOR
Intervention: IF technique (Italy)
Number of subjects: 122
Study: 8095137

Group type: EXPERIMENTAL
Intervention: Exposure in vivo followed by cognitive therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cognitive therapy followed by exposure in vivo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment integrating both strategies from the start
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 30
Study: 3308969

Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Subgingival curettage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pocket elimination surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Modified Widman flap surgery
Number of subjects: 90
Study: 30703872

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (ethyl ester form of eicosapentaenoic acid, EPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acid supplementation
Number of subjects: 0
Study: 27056687

Group type: EXPERIMENTAL
Intervention: Fixed tibial platform TKA (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mobile tibial platform TKA (group B)
Number of subjects: 0
Study: 25226322

Group type: EXPERIMENTAL
Intervention: Barbell deadlift training (twice per week for 10 weeks)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Barbell deadlift training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 23566308

Group type: EXPERIMENTAL
Intervention: Sucrose beverage
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-nutrient sweetened beverage
Number of subjects: 20
Study: 21455716

Group type: EXPERIMENTAL
Intervention: CaD group (800 mg calcium and 10 μg vitamin D(3), n = 26)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: CaDK1 group (800 mg calcium, 10 μg vitamin D(3), and 100 μg vitamin K(1), n = 26)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: CaDK2 group (800 mg calcium, 10 μg vitamin D(3), and 100 μg vitamin K(2), n = 24)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (usual diet, n = 39)
Number of subjects: 115
Study: 18377136

Group type: EXPERIMENTAL
Intervention: Postal questionnaire measuring cognitions about donation
Number of subjects: 4672

Group type: COMPARATOR
Intervention: Control condition (no questionnaire)
Number of subjects: 4672
Study: 16828501

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (4 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (subconjunctival saline)
Number of subjects: 43
Study: 12617276

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (500 mg daily for five days with a 10-day tapering period)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 11073757

Group type: EXPERIMENTAL
Intervention: Ritonavir and saquinavir with stavudine
Number of subjects: 208

Group type: COMPARATOR
Intervention: Ritonavir and saquinavir without stavudine
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Continued ARVT during LEE
Number of subjects: 208
Study: 10160479

Group type: EXPERIMENTAL
Intervention: Alprostadil
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 91
Study: 1470022

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) stretching in Anterior Pelvic Tilt (APT) position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Static Stretch (SS) in Anterior Pelvic Tilt (APT) position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) stretching in Posterior Pelvic Tilt (PPT) position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Static Stretch (SS) in Posterior Pelvic Tilt (PPT) position
Number of subjects: 20
Study: 6379459

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 42
Study: 30961947

Group type: EXPERIMENTAL
Intervention: Carvacrol (1.2 mg/kg/day)
Number of subjects: 21
Study: 30376838

Group type: EXPERIMENTAL
Intervention: Matured hop extract (MHE) for 12 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 200
Study: 25688811

Group type: EXPERIMENTAL
Intervention: eBridge (online intervention with personalized feedback and optional online counseling)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control condition (personalized feedback only, offered in plain report format)
Number of subjects: 76
Study: 23676264

Group type: EXPERIMENTAL
Intervention: Alternate Mediterranean diet adherence score
Number of subjects: 6174

Group type: EXPERIMENTAL
Intervention: Higher monounsaturated-to-saturated fats ratio
Number of subjects: 6174

Group type: EXPERIMENTAL
Intervention: Greater whole grain intake
Number of subjects: 6174
Study: 21414653

Group type: EXPERIMENTAL
Intervention: Transobturator tapes (inside-out TVT-O or outside-in TOT-ARIS)
Number of subjects: 46
Study: 19729128

Group type: EXPERIMENTAL
Intervention: Periodic training subjects (PTS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypokinetic subjects (HKS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active control subjects (ACS)
Number of subjects: 30
Study: 18201583

Group type: EXPERIMENTAL
Intervention: FDC ARV tablet for oral suspension (lamivudine 40 mg, nevirapine 70 mg, stavudine 10 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Individual liquid formulations (lamivudine 10 mg/mL, nevirapine 50 mg/5 mL, stavudine 1 mg/mL)
Number of subjects: 36
Study: 15064389

Group type: EXPERIMENTAL
Intervention: 14‐Gy centered endovascular irradiation (irradiation group, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No irradiation (control group, n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 14‐Gy centered endovascular irradiation (irradiation group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No irradiation (control group)
Number of subjects: 30
Study: 11566069

Group type: EXPERIMENTAL
Intervention: Furosemide (1 mg/kg) administered intravenously during dehydration
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control condition (no furosemide, hydration maintained)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dehydration (induced by furosemide)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Correlation with glucagon
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dehydration effects on potassium and sodium excretion
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Change in reactivity of urea synthesis to glucagon
Number of subjects: 7
Study: 9714487

Group type: EXPERIMENTAL
Intervention: CABG with CPB
Number of subjects: 57

Group type: COMPARATOR
Intervention: MIDCAB without CPB
Number of subjects: 57
Study: 9248869

Group type: EXPERIMENTAL
Intervention: Duloxetine hydrochloride 20 mg daily for 6 weeks
Number of subjects: 79
Study: 1937608

Group type: EXPERIMENTAL
Intervention: Catheter with stillete
Number of subjects: 100

Group type: COMPARATOR
Intervention: Catheter without stillete
Number of subjects: 100
Study: 7095604

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) and dihydroergotamine (DHE) combined treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) alone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Dihydroergotamine (DHE) alone
Number of subjects: 150
Study: 30397078

Group type: EXPERIMENTAL
Intervention: PRISM implementation
Number of subjects: 230099
Study: 30235716

Group type: EXPERIMENTAL
Intervention: Esketamine (0.25 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 0
Study: 26485439

Group type: EXPERIMENTAL
Intervention: CPAP treatment at 14 cm H2 O
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo treatment at 0 cm H2 O
Number of subjects: 54
Study: 24711067

Group type: EXPERIMENTAL
Intervention: NeuroAiD
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 22892913

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 16
Study: 20150747

Group type: EXPERIMENTAL
Intervention: Specialist care (SP)
Number of subjects: 308

Group type: COMPARATOR
Intervention: General practitioner care (GP)
Number of subjects: 308
Study: 18611277

Group type: EXPERIMENTAL
Intervention: Supervised walking programme (3 sessions of 50 minutes per week for 6 months)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Best primary care (control group)
Number of subjects: 106
Study: 16010540

Group type: EXPERIMENTAL
Intervention: 0.05 and 0.1 mg of pergolide (direct DA agonist)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 100 and 200 mg of amantadine (indirect DA agonist)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 11899956

Group type: EXPERIMENTAL
Intervention: Silzone valves
Number of subjects: 807

Group type: COMPARATOR
Intervention: Conventional valves
Number of subjects: 807
Study: 10087750

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Prednisolone plus azathioprine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Betamethasone‐cyclophosphamide pulse (BCP) therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Azathioprine-corticosteroid treatment
Number of subjects: 72
Study: 7836734

Group type: COMPARATOR
Intervention: Captopril (150 mg/day for 3 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nafamostat (0.2 mg/kg per h) during exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline during exercise
Number of subjects: 6
Study: 3350283

Group type: EXPERIMENTAL
Intervention: Balloon distention of the stomach with 100, 200, or 300 ml of water
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infusion of lipid into the duodenum at 1.5 ml/min for 30 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infusion of cholecystokinin-octapeptide intravenously at 20 ng/kg.h
Number of subjects: 16
Study: 29282713

Group type: EXPERIMENTAL
Intervention: Responders
Number of subjects: 308

Group type: COMPARATOR
Intervention: Non-responders
Number of subjects: 308